article thumbnail

Reshaping events in pharma

pharmaphorum

Healthcare professional (HCP) engagement experienced significant shifts during the acute phase of the pandemic, as COVID-19 forced a rethink of traditional pharmaceutical sales and marketing practices, including the digitisation of events. The changing events model. Before COVID, pharma events were mainly face-to-face.

article thumbnail

ACI To Host Multiple Events Featuring HP&M Speakers – Discounts Available to FDA Law Blog Readers

The FDA Law Blog

HP&M is proud to have our professionals participating in these important events. His practice supports clients throughout the life sciences from biotech startups and multinational pharmaceutical companies to CROs and academic researchers to patient advocacy organizations. On March 20-21, Counsel John W.M.

FDA 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Engaging Communities through High-Impact Healthcare Sponsorships in the Pharmaceutical Industry 

Pharma Marketing Network

Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceutical companies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way.

article thumbnail

Experts to come together for compliance event ‘validation ready’ global labeling systems  

pharmaphorum

Experts to come together for compliance event . A group of industry experts is set to explore how medical device, clinical trial and pharmaceutical companies can proactively manage labeling risk. The post Experts to come together for compliance event ‘validation ready’ global labeling systems appeared first on.

article thumbnail

STAT+: Novartis is scolded by U.K. trade group for the fourth time this year over Entresto promotions

STAT

trade group for misleading promotional efforts for its biggest-selling drug and, in the process, failing to maintain high standards expected of pharmaceutical companies. For the fourth time this year, Novartis has been reprimanded by a U.K.

article thumbnail

Viseven at Pharma Xchange: Switching to Omnichannel in Korea

Viseven

Starting this year, most pharmaceutical companies in South Korea plan to switch from multichannel to omnichannel marketing with the help of content production, cross-functional change management, and effective KPI monitoring. We look forward to innovative changes in the digital marketing of Korean pharmaceutical companies!”,—

article thumbnail

Anticipating ASCO 2024: Perspectives from Oncologists

InCrowd

Attendance Outlook: An impressive 72% of oncologists, whether attending in-person or virtually, are gearing up for ASCO 2024, underscoring the event’s importance in the oncology community. Exciting Topics on the Horizon Topics ranging from groundbreaking research to innovative therapies have captured the interest of oncologists.